Navigation Links
Non-Hormonal Therapies Aid Breast Cancer Patients
Date:12/9/2008

tiveness in both untreated and previously treated patients means that other considerations, such as toxicity, will continue to help determine the choice of regimen for individual patients, the researchers said.

"Although this network meta-analysis is unlikely to alter routine clinical practice, it provides a solid evidence-based foundation to support the observation that the survival of women diagnosed with advanced breast cancer has improved because of more active systemic chemotherapy and targeted therapy," Bedard and Piccart-Gebhart wrote. "This should provide hope to patients, investigators, industrial sponsors, and regulatory agencies alike that well-designed clinical trials with novel systemic therapies can further alter the natural history of this devastating disease."

More information

Breastcancer.org has more about recurrent and metastatic breast cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute, news release, Dec. 9, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Bogus Stem Cell Therapies Sold on Internet
2. Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017
3. Non-white med students reject therapies associated with their culture
4. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
5. Stem cell therapies for heart disease -- 1 step closer
6. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
7. Study shows steroid therapies following transplant can be eliminated
8. Study Evaluates Laser Therapies for Hair Removal
9. New Journal to Explore Neurodegenerative, Neuroprotective and Euroregenerative Therapies!
10. New way to control protein activity could lead to cancer therapies
11. Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 (HealthDay News) -- Obesity increases the risk of ... Hispanic women, two new U.S. studies show. One ... overweight or obese increased the risk for estrogen receptor-negative ... "We,ve known this for a long time for white ... Hispanic women," study author Esther John, a senior research ...
(Date:10/31/2014)... 31, 2014 Gold Medal Wine Club ... affordable but tasteful gifts for the wine novice and enthusiasts ... Bird Gift Giving Special , which Early Bird shoppers receive ... Wine Club Gift membership. , Gift Givers must place ... special. Besides offering discounts, Gold Medal Wine Club adds more ...
(Date:10/31/2014)... Fl. (PRWEB) October 31, 2014 ... for boys and girls in grades 6-12, is ... potential for sports injuries and concussions, becoming the ... administer the ImPACT (Immediate Post-Concussion Assessment and Cognitive ... a 'Former NFL Player' lawsuit grabs the headlines, ...
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... , the U.S. indoor air quality (IAQ) market is expected ... annual growth rate (CAGR) of 7% over the next five ... a CAGR of 7.4%. , Since 2012, continuing media ... outbreak of infectious diseases such as bird flu and the ...
(Date:10/31/2014)... 2014 (HealthDay News) -- A few simple steps can help ... sleep expert says. "Adjusting to the end of Daylight ... handling the time change in the spring. The main reason ... fall time change," Dr. Praveen Rudraraju, director of the Center ... N.Y., said in a hospital news release. The many ...
Breaking Medicine News(10 mins):Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3Health News:Make the Most of This Weekend's Time Change 2
... ... of opium and heroin addicts within Afghanistan. There are only 40 drug ... and the capital city of Kabul. In winter months, the U.N. recorded ... ruining families who do not know the dangers of opium and heroin use. ...
... (March 31, 2010) Healthy pre-and post-menopausal ... containing Natural S-equol, a novel soy germ-based ingredient ... had measures of reproductive hormones that stayed within ... data were presented at the American Medical Women,s ...
... Researchers think they know how cytomegalovirus continues to re-infect people ... light on how a virus known as cytomegalovirus (CMV), which ... age 40, re-infects people again and again even though their ... infection doesn,t always make people ill, but certain people, such ...
... nanometer-scale probe designed to slip into a cell wall and ... eavesdropping on the inner electrical activity of individual cells. ... to "digestive rumblings" as cells react to medication could be ... Current methods of probing a cell are so destructive they ...
... PHOENIX, Ariz. April 1, 2010 Dr. Daniel D. ... has won a top award from the American Society of ... Hoff, M.D., F.A.C.P., will receive the 2010 David A. Karnofsky ... 4-8 at the McCormick Place in Chicago. ASCO will ...
... shows drug resistance can be lost, treatment can work again ... a mechanism by which certain tumor cells that become resistant ... The discovery may lead to new ways to combat drug ... study, published online April 1 in the journal Cell ...
Cached Medicine News:Health News:Interview: Heroin Addicts in Afghanistan: An Inside Look 2Health News:Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women 2Health News:Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women 3Health News:Novel soy germ-based dietary supplement, SE5-OH containing natural S-Equol, examined for safety and influence on hormones in pre- and post-menopausal women 4Health News:Demystifying a Common, Persistent Virus 2Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 2Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 3Health News:TGen Physician-In-Chief Dr. Daniel D. Von Hoff wins ASCO award 2Health News:Study Suggests How Some Cancers Resist Treatment 2Health News:Study Suggests How Some Cancers Resist Treatment 3
(Date:10/31/2014)... NEW YORK , October 31, 2014 ... regarding Celgene Corporation (NASDAQ: CELG ), Bristol-Myers ... Inc. (NYSE: UNH ), Sanofi SA (NYSE: ... Private wealth members receive these notes ahead of publication. ... http://www.analystsreview.com/7593-100free . , ,-- ,Celgene Corporation Research Reports ...
(Date:10/31/2014)... VIEW, Calif. , Oct. 31, 2014 ... lateral sclerosis (ALS) patients initiate text and email messages ... upon a patent-pending technology invented by ThynkWare,s founder, ... assistant on a smartphone device. This technology allows users ... using only the power of thought. ThynkWare ...
(Date:10/31/2014)... MELBOURNE, Australia and BARCELONA , ... Pty Ltd (Multigate) was found to infringe two Australian patents ... offering for sale in Australia safety ... of 17.10.14 in Federal Court of Australia ... at http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed ...
Breaking Medicine Technology:Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2
... Baxter,International Inc. today announced final Phase I/II data ... to initiate a Phase III clinical trial of ... results. , The Phase I/II study indicated that ... doses, and induces substantial,levels of cross immunity against ...
... Dr. H. Bryan Brewer, Jr. Sees Enormous Potential ... (MARKET WIRE via COMTEX News Network),-- Lipid Sciences, ... Scientific Director of Lipid Sciences, Inc., concluded from,the ... College of,Cardiology (ACC) Meeting in New Orleans that ...
Cached Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
... The Auto Suture™ ... inclusive of five (5) ... application in a variety ... urologic, colorectal and other ...
... RETRACT™ 12 mm instrument has application in ... and other endoscopic procedures for retracting internal ... , ,The ENDO PADDLE RETRACT™ instrument ... distal end of the instrument and is ...
... Introducing the widest offering of single-use instruments ... and long 43cm lengths for Bariatric Surgery. ... , Extended insulation covers the pivot points to ... , A 4mm universal cord, which eliminates gapping ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: